Arcelik AS
F:RCAA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arcelik AS
F:RCAA
|
TR |
|
S
|
Sutro Biopharma Inc
F:S09
|
US |
|
I
|
Innostar Service Inc
TPEX:7828
|
TW |
|
A
|
Associated Banc-Corp
F:AB5
|
US |
|
H
|
Hulic Co Ltd
F:87W
|
JP |
|
G
|
Gas Plus SpA
F:T9O
|
IT |
Wall St Price Targets
RCAA Price Targets Summary
Arcelik AS
According to Wall Street analysts, the average 1-year price target for RCAA is 12.66 EUR with a low forecast of 10.08 EUR and a high forecast of 15.54 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RCAA's stock price target?
Price Target
12.66
EUR
According to Wall Street analysts, the average 1-year price target for RCAA is 12.66 EUR with a low forecast of 10.08 EUR and a high forecast of 15.54 EUR.
What is the Revenue forecast for Arcelik AS?
Projected CAGR
26%
Over the last 8 years, the compound annual growth rate for Revenue has been 50%. The projected CAGR for the next 7 years is 26%.
What is the Gross Profit forecast for Arcelik AS?
Projected CAGR
27%
Over the last 8 years, the compound annual growth rate for Gross Profit has been 48%. The projected CAGR for the next 3 years is 27%.
What is the Operating Income forecast for Arcelik AS?
Projected CAGR
69%
Over the last 8 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 7 years is 69%.
